Method and apparatus for dissolution testing of a dosage form

• US 5,412,979 A
• Filed: 05/03/1993
• Issued: 05/09/1995
• Est. Priority Date: 05/03/1993
• Status: Expired due to Fees

• Current Assignee: Temple University of The Commonwealth System of Higher Education
• Original Assignee: Temple University of The Commonwealth System of Higher Education
• Inventors: Fassihi, Alireza D.
• Primary Examiner(s): Noland, Thomas P.
• Assistant Examiner(s): WIGGINS, JOHN DAVID
• Application Number:
  US08/056,636
• Time in Patent Office: 736 Days
• Field of Search: 73/866, 73/864.83, 73/863.23, 73/64.55, 73/53.01, 422/101, 422/102, 424/449
• US Class Current: 73/53.01
• CPC Class Codes: B01F 21/15 comprising constructions for blocking or redispersing undissolved solids, e.g. sieves, separators or guiding constructions B01F21/221 takes precedence
• CPC Class Codes: B01F 27/115 comprising discs or disc-like elements essentially perpendicular to the stirrer shaft axis
• CPC Class Codes: B01F 27/80 with stirrers rotating about a substantially vertical axis
• CPC Class Codes: G01N 13/00 Investigating surface or boundary effects, e.g. wetting power; Investigating diffusion effects; Analysing materials by determining surface, boundary, or diffusion effects scanning-probe techniques or apparatus G01Q
• CPC Class Codes: G01N 2013/006 Dissolution of tablets or the like
• CPC Class Codes: G01N 33/15 Medicinal preparations ; Physical properties thereof, e.g. dissolubility

Abstract

An apparatus and method determines the dissolution of a drug from a dosage form, most particularly a swellable dosage form. An inert, transparent cylindrical vessel having a hemispherical bottom contains a fluid medium. The dosage form is placed into the vessel. A disk carried in the vessel has a pair of annular rings for engaging the vessel walls spaced above the bottom of the vessel. The disk has a screen mesh circumferentially sandwiched by the rings for passage of the fluid medium through the disk. A dosage form retaining space defined between the disk and bottom of the vessel retains the dosage form. The disk restrains the dosage form from floating to the top of the fluid medium. A stirring mechanism having a vertical shaft and a blade at a lower end of the shaft is inserted into the vessel. The stirring mechanism rotates the fluid medium. The drug concentration in the fluid medium is sampled at selected time intervals.

Claims

1. An apparatus for testing the dissolution of a dosage form, comprising:

an inert cylinder vessel adapted to hold a fluid medium having a bottom;

a stirring mechanism depending into the vessel for rotating the fluid medium; and

a disk positioned in the vessel adapted to engage the vessel wall at a location spaced from the vessel bottom, the disk having a plurality of holes for passage, of the fluid medium therethrough; and

the disk lower surface and the vessel bottom defining a dosage form retaining space for retaining and allowing movement of the dosage form in the volume between the vessel bottom and the disk.

2. An apparatus according to claim 1 wherein the disk has a screen mesh having the plurality of holes.

3. An apparatus according to claim 2 wherein the cylindrical vessel is transparent and the bottom is hemispherical with concave surface facing upward.

4. An apparatus according to claim 3 wherein the stirring mechanism is a paddle having a blade at a lower end of a shaft.

5. An apparatus according to claim 4 wherein the screen mesh of the disk is spaced from the bottom of the vessel by a distance of from about 35 millimeters to about 45 millimeter and spaced from the paddle by a distance of from about 17 millimeter to about 23 millimeters.

6. An apparatus for testing dissolution of a swellable, floatable dosage form comprising:

an inert, transparent cylindrical vessel adopted to hold a fluid medium having a hemispherical concave bottom;

a stirring mechanism having a vertical shaft adapted to depend into the fluid medium and a blade at a lower end of the shaft for rotating the fluid medium; and

a disk positioned in the vessel spaced from the vessel bottom, the disk comprising a pair of annular rings adapted to engage the vessel and a screen mesh circumferentially sandwiched by the rings to allow passage of the fluid medium through the disk screen mesh;

a dosage form retaining space defined by the volume intermediate to the disk and the vessel bottom for containing the dosage form.

7. An apparatus according to claim 6 wherein the screen mesh of the disk is spaced from the bottom of the vessel by a distance of from about 35 millimeters to about 45 millimeter and spaced from the paddle by a distance of from about 17 millimeter to about 23 millimeters.

8. An apparatus for limiting floatation of a dosage form in a drug dissolution testing vessel comprising an annular ring assembly circumferentially enclosing and surrounding a screen mesh, the ring assembly having an outwardly circumferentially edge for contacting the vessel wall a selected distance from the vessel bottom to form a dosage form retaining space defined by the volume intermediate to the disk and the vessel bottom.

9. An apparatus according to claim 8 wherein the annular ring assembly comprises first and second concentric mating annular rings sandwiching the screen mesh between the peripheral edges of said first and second annular rings.

10. A method for testing the dissolution of a drug from a dosage form comprising:

providing an inert cylindrical vessel having a hemispherical concave bottom containing a fluid medium;

placing the dosage form in the vessel;

inserting a disk into the vessel which engages the vessel wall at a location above the dosage form, thereby forming a dosage form retaining space for retaining the dosage form in the fluid volume under the disk, the disk having a plurality of holes for passage of the fluid medium therethrough;

inserting a stirring mechanism having a vertical shaft and a blade at a lower end of the shaft into the vessel;

rotating the stirring mechanism to circulate the fluid medium in the vessel;

sampling the drug concentration in the fluid medium at selected time intervals.

11. A method according to claim 10 wherein the disk comprises an annular ring circumferentially enclosing a screen mesh.

12. A method according to claim 10 wherein the dosage form is swellable, floatable dosage form and the disk limits upward movement of the swellable, floatable dosage form in the fluid medium.

13. In combination an apparatus and dosage form for testing of the dosage form, the combination comprising:

an inert cylindrical vessel adapted to hold a fluid medium having a bottom, a stirring mechanism depending into the vessel for rotating the fluid medium, and a disk positioned in the vessel adapted to engage the vessel wall at a location spaced from the vessel bottom, the disk having a plurality of holes for passage of the fluid medium therethrough;

a swellable, floatable dosage form adapted for three dimensional swelling and a drug release over a specific period of time; and

a dosage form retaining space defined by the volume intermediate to the disk and the vessel bottom for retaining and allowing floating and swelling of the dosage form between the vessel bottom and the disk.